Are Fertility Drugs A Threat For Ovarian Cancer?

Ovarian Cancer and Fertility DrugsAll women out there! Go through this passage for a well confirmation of the relation of fertility drugs with the ovarian cancer.

Do not neglect, read now! First of all know some hard core facts of ovarian cancer and how the fertility drugs work.

Ovarian cancer stands four in the cause of cancer deaths in women.

Every year over 25,000 women are diagnosed with this disease and most of us have a less that 2% lifetime chance of developing ovarian cancer.

While facts are that this disease is very treatable when detected early, unfortunately 75 percent of new cases are not diagnosed until the disease is in its late stages of development recently; this is where the treatment becomes less effective.

Survival rate of over 90 percent is possible with early detection; however diagnosis in its later stages dramatically reduces the chances of survival to just 25 percent.

How do they work? Many fertility drugs have been used safely and successfully for more than 30 years. Unlike many other infertility solutions, such as in vitro fertilization, fertility drugs won’t increase the chance of multiple births beyond 5 to 15 percent.

Fertility drugs work by promoting ovulation by stimulating hormones in a woman’s brain to get an egg or many. These eggs are ready for release each month. The most common fertility drugs include Human Menopausal Gonadotrophin, Bromocriptine and Clomiphene

Average Risk! Studies conducted by University of Pittsburgh reveal that fertility drugs do not put women at a higher than average risk of this disease, according to the largest analysis to date on the topic.

For more than a decade, controversy goes on among infertility, ovarian cancer and fertility drugs, how much is the risk. While no association was found between ovarian cancer and fertility drugs, the study does point out a link between ovarian cancer and certain specific causes of infertility.

The risk of this disease is dropped with each pregnancy. Women who had used fertility drugs were not more likely to develop ovarian cancer than those who had never used fertility drugs.

Also, the infertile women who were most likely to develop this disease were those whose infertility resulted from endometriosis or from “unknown” causes.

It should be noted that some women because of underlying conditions that cause infertility develop ovarian cancer and not because of the treatments themselves. It has long been known that pregnancy protects against this disease.

In this study, women who were able to become pregnant, even if they did not give birth, were not at a higher risk for cancer.

The association between ovarian cancer and fertility drugs was seen principally in those who never became pregnant; suggesting that possibly the type of infertility rather than the drug use itself may be associated with risk for ovarian cancer.

Suggestion! All women who have had treatments with fertility drugs should have ovarian cancer screening performed once a year in much the same way as they have routine Pap tests done.

Ovarian cancer screening includes transvaginal ultrasonography, pelvic examination and others. Consult your doctor for further details today.